- Nachrichtendetail
-
03.07.2024 14:04:13 - dpa-AFX: *J&J : HEALTH CANADA AUTHORIZES RYBREVANT COMBINATION FOR EGFR EXON 20 NON-SMALL CELL LUNG CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Xetra | 147,020 | 30.07.24 15:34:42 | -0,440 | -0,30% | 146,640 | 146,800 | 146,400 | 147,460 |
